Search
for

    Sort by

    Research 61–90 of 470

    1. Alopecia Elsevier eBooks · 2018
    2. Benign Cutaneous Eruptions After Transplantation Springer eBooks · 2017
    3. An immune regulatory CCT repeat containing oligodeoxynucleotide capable of causing hair loss in male mice Human & Experimental Toxicology · 2016
    4. Generalized hypertrichosis associated with the use of interleukin 17 blockers in 2 patients with psoriasis JAAD Case Reports · 2020 · 3 citations
    5. New Drugs: Dutasteride Australian Prescriber · 2009
    6. ESGCT and FSGT Collaborative Congress Helsinki, Finland September 17–20, 2015 Abstracts Human Gene Therapy · 2015 · 2 citations
    7. Adverse Reactions to Biologic Medications Used in Allergy and Immunology Diseases Current Allergy and Asthma Reports · 2022 · 2 citations
    8. Safety of Biological Therapies for Severe Asthma: An Analysis of Suspected Adverse Reactions Reported in the WHO Pharmacovigilance Database BioDrugs · 2024 · 1 citations
    9. Alopecia Universalis Occurring after Alemtuzumab Treatment for Multiple Sclerosis. A Two-Year Follow-Up of Two Patients 2021 · 3 citations
    10. PC-SPES Studies Promising, But Manufacturer Shuts Down Oncology Times · 2002
    11. Trastuzumab Induced Chemobrain, Atorvastatin Rescued Chemobrain with Enhanced Anticancer Effect and without Hair Loss-Side Effect Journal of clinical medicine · 2019 · 15 citations
    12. Canadian Expert Recommendations on Safety Overview and Toxicity Management Strategies for Sacituzumab Govitecan Based on Use in Metastatic Triple-Negative Breast Cancer Current Oncology · 2024 · 6 citations
    13. Induction plus adjuvant chemotherapy, combined treatment with nimotuzumab, and intensity-modulated radiation therapy for N3 stage nasopharyngeal carcinoma Journal of Cancer Research and Therapeutics · 2021 · 6 citations
    14. Case Report: Omalizumab-associated hair loss: a case of eyebrow alopecia areata, literature review and FAERS database analysis Frontiers in Medicine · 2025
    15. Understanding, recognizing, and managing toxicities of targeted anticancer therapies Ca · 2013 · 278 citations
    16. Proteolysis‐Targeting Chimera (PROTAC): Current Applications and Future Directions MedComm · 2025 · 9 citations
    17. Long-Term Survival of Type XVII Collagen Revertant Cells in an Animal Model of Revertant Cell Therapy Journal of Investigative Dermatology · 2013 · 27 citations
    18. Cutaneous Involvement in Systemic Lupus Erythematosus: A Review for the Rheumatologist The Journal of Rheumatology · 2022 · 11 citations
    19. Biologics and Small Molecules for Inflammatory Nail Disorders: A Narrative Review Indian Dermatology Online Journal · 2024 · 1 citations
    20. Does Complement Have a Role in the Pathogenesis of Alopecia Areata? Skin appendage disorders · 2018 · 1 citations
    21. DKK3–CKAP4 signaling drives fibroimmune remodeling and hair follicle miniaturization in androgenetic alopecia Theranostics · 2026
    22. SnapshotDx Quiz: May 2020 2020
    23. What's new in the pathogeneses and triggering factors of bullous pemphigoid The Journal of Dermatology · 2022 · 46 citations
    24. The Influence of Allium cepa Extracts on Promotion of Hair Growth 한국생물공학회 학술대회 · 2009 · 1 citations
    25. Oral Lichen Planus InTech eBooks · 2013 · 7 citations
    26. Industry Updates from the Field of Stem Cell Research and Regenerative Medicine in December 2019 Regenerative Medicine · 2020 · 1 citations
    27. Recent Advances in Drug Development for Hair Loss International Journal of Molecular Sciences · 2025
    28. Recent Advances in Understanding of the Etiopathogenesis, Diagnosis, and Management of Hair Loss Diseases Journal of Clinical Medicine · 2023
    29. Efficacy and safety of trastuzumab deruxtecan in the treatment of HER2-low/positive advanced breast cancer: a single-arm meta-analysis Frontiers in Pharmacology · 2023 · 13 citations
    30. The JAK/STAT signaling pathway: from bench to clinic Signal Transduction and Targeted Therapy · 2021 · 489 citations